BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10426380)

  • 1. Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes.
    Weyer C; Bogardus C; Pratley RE
    Diabetes; 1999 Aug; 48(8):1607-14. PubMed ID: 10426380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
    Weyer C; Bogardus C; Pratley RE
    Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.
    Weyer C; Tataranni PA; Bogardus C; Pratley RE
    Diabetes Care; 2001 Jan; 24(1):89-94. PubMed ID: 11194248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
    Salinitri FD; Pinelli NR; Martin ET; Jaber LA
    Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus.
    Koska J; Ortega E; Bogardus C; Krakoff J; Bunt JC
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E264-9. PubMed ID: 17616607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.
    Ohashi K; Komada H; Uda S; Kubota H; Iwaki T; Fukuzawa H; Komori Y; Fujii M; Toyoshima Y; Sakaguchi K; Ogawa W; Kuroda S
    PLoS One; 2015; 10(12):e0143880. PubMed ID: 26623647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight.
    Weyer C; Hanson K; Bogardus C; Pratley RE
    Diabetologia; 2000 Jan; 43(1):36-46. PubMed ID: 10663214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study].
    Henkel E; Köhler C; Temelkova-Kurktschiev T; Hanefeld M
    Dtsch Med Wochenschr; 2002 May; 127(18):953-7. PubMed ID: 11987015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Weyer C; Bogardus C; Mott DM; Pratley RE
    J Clin Invest; 1999 Sep; 104(6):787-94. PubMed ID: 10491414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.
    Kanauchi M; Nakajima M; Saito Y; Kanauchi K
    Metabolism; 2003 Apr; 52(4):476-81. PubMed ID: 12701062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
    Bajraktari G; Koltai MS; Ademaj F; Rexhepaj N; Qirko S; Ndrepepa G; Elezi S
    Int J Cardiol; 2006 Jun; 110(2):206-11. PubMed ID: 16297997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.
    Fiorentino TV; Marini MA; Andreozzi F; Arturi F; Succurro E; Perticone M; Sciacqua A; Hribal ML; Perticone F; Sesti G
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3744-51. PubMed ID: 26274345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.